PPA
RCUS icon

Parametric Portfolio Associates’s Arcus Biosciences RCUS Stock Holding History

Parametric Portfolio Associates’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$2.3M Buy
72,994
+19,018
+35% +$637K ﹤0.01% 2344
2021
Q4 		$2.18M Buy
53,976
+24,059
+80% +$933K ﹤0.01% 2387
2021
Q3 		$1.04M Buy
29,917
+145
+0.5% +$4.51K ﹤0.01% 2795
2021
Q2 		$818K Sell
29,772
-4,873
-14% -$139K ﹤0.01% 2861
2021
Q1 		$973K Buy
34,645
+5,335
+18% +$186K ﹤0.01% 3175
2020
Q4 		$761K Buy
29,310
+7,973
+37% +$193K ﹤0.01% 3185
2020
Q3 		$366K Sell
21,337
-29,869
-58% -$667K ﹤0.01% 3404
2020
Q2 		$1.27M Buy
51,206
+34,584
+208% +$933K ﹤0.01% 2788
2020
Q1 		$231K Buy
+16,622
New +$207K ﹤0.01% 3490

Other funds holding RCUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return